Rosen Law Firm Investigates Disc Medicine, Inc. Over Allegations of Misleading Investor Information

Rosen Law Firm is investigating potential securities fraud claims against Disc Medicine, Inc. (NASDAQ: IRON), a biotech company, according to AP News. The law firm says Disc Medicine may have given investors misleading information about its business. Investors who bought IRON shares may be entitled to compensation at no out-of-pocket cost.
The firm is building a class action lawsuit to recover investor losses, PR Newswire reported. A class action lets a group of investors sue a company together. Rosen Law Firm says investors can join the case by visiting its website or calling attorney Phillip Kim.
Rosen Law Firm says Disc Medicine may have put out false or misleading information to the public, according to AP News. This is called a "material misstatement" in securities law. It means a company says something that changes how investors feel about buying or selling its stock. The firm has not yet said exactly what statements were misleading.
Disc Medicine trades on the NASDAQ stock exchange under the ticker symbol IRON. The company focuses on treatments for blood disorders. No formal lawsuit has been filed yet. The investigation is still in its early stage, Barchart noted.
Investors who bought IRON shares do not need to pay anything upfront to join the case. Rosen Law Firm works on a contingency fee basis. That means the firm only gets paid if it wins money for investors. This makes it easier for everyday investors to take legal action against large companies.
To get involved, investors can contact Phillip Kim, Esq. directly at Rosen Law Firm or sign up through the firm's website, AP News reported. The firm has not set a public deadline for joining, but investors are encouraged to act quickly. Early participation can matter in class action cases.
Rosen Law Firm calls itself a global investor rights firm. ISS Securities Class Action Services ranked it No. 1 for the most securities class action settlements in 2017, according to PR Newswire. The firm says it represents investors around the world in cases like this one.
The firm is also running a separate investigation into Manhattan Associates, Inc. (NASDAQ: MANH), looking at possible breaches of duty by its directors and officers, AP News reported. This shows Rosen Law is actively pursuing multiple corporate investigations at the same time.
If the investigation leads to a lawsuit and a settlement, shareholders who bought IRON stock during a specific time period could get money back. The exact time window has not been announced yet. Courts decide who qualifies based on when they bought shares and how much they lost.
Securities class actions are a common way investors seek justice after a stock drops due to alleged fraud. Not every investigation becomes a lawsuit. But if Rosen Law finds strong evidence, a formal complaint could be filed in federal court, PR Newswire noted.
Publishers
3
Articles
3
Reach
4